199 related articles for article (PubMed ID: 35121197)
1. Generation and characterization of induced pluripotent stem cell (iPSC) lines of two asymptomatic individuals carrying a heterozygous exon 7 deletion in Parkin (PRKN) and two non-carriers from the same family.
Castelo Rueda MP; Gilmozzi V; Riekschnitz DA; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I; Zanon A
Stem Cell Res; 2022 Apr; 60():102692. PubMed ID: 35121197
[TBL] [Abstract][Full Text] [Related]
2. Generation of an induced pluripotent stem cell line (EURACi005-A) from a Parkinson's disease patient carrying a homozygous exon 3 deletion in the PRKNgene.
Zanon A; Riekschnitz D; von Troyer M; Volpato C; Picard A; Cantaloni C; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I
Stem Cell Res; 2019 Dec; 41():101624. PubMed ID: 31715428
[TBL] [Abstract][Full Text] [Related]
3. Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene.
Pavan C; Jin J; Jong S; Strbenac D; Davis RL; Sue CM; Johnston J; Lynch T; Halliday G; Kirik D; Parish CL; Thompson LH; Ovchinnikov DA
Stem Cell Res; 2023 Dec; 73():103211. PubMed ID: 37890334
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
[TBL] [Abstract][Full Text] [Related]
5. Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson's disease with PARK2 mutation.
Ishikawa KI; Okuzumi A; Yoshino H; Hattori N; Akamatsu W
Stem Cell Res; 2024 Apr; 76():103323. PubMed ID: 38309147
[TBL] [Abstract][Full Text] [Related]
6. Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing.
Chen CX; You Z; Abdian N; Sirois J; Shlaifer I; Tabatabaei M; Boivin MN; Gaborieau L; Karamchandani J; Beitel LK; Fon EA; Durcan TM
Stem Cell Res; 2022 Jul; 62():102806. PubMed ID: 35561458
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's disease.
Zhu W; Huang X; Yoon E; Bandres-Ciga S; Blauwendraat C; Billingsley KJ; Cade JH; Wu BP; Williams VH; Schindler AB; Brooks J; Gibbs JR; Hernandez DG; Ehrlich D; Singleton AB; Narendra DP
Brain; 2022 Jun; 145(6):2077-2091. PubMed ID: 35640906
[TBL] [Abstract][Full Text] [Related]
8. Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations.
Chen M; Maimaitili M; Buchholdt SH; Jensen UB; Febbraro F; Denham M
Stem Cell Res; 2020 Jan; 42():101657. PubMed ID: 31786474
[TBL] [Abstract][Full Text] [Related]
9. Parkin mutations and early-onset parkinsonism in a Taiwanese cohort.
Wu RM; Bounds R; Lincoln S; Hulihan M; Lin CH; Hwu WL; Chen J; Gwinn-Hardy K; Farrer M
Arch Neurol; 2005 Jan; 62(1):82-7. PubMed ID: 15642853
[TBL] [Abstract][Full Text] [Related]
10. A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson's Disease Arising from Parkin Mutations.
Li D; Aung-Htut MT; Ham KA; Fletcher S; Wilton SD
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019779
[TBL] [Abstract][Full Text] [Related]
11. Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson's disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004).
Novak G; Finkbeiner S; Skibinski G; Bernini M; Donato C; Skupin A
Stem Cell Res; 2022 May; 61():102765. PubMed ID: 35378365
[TBL] [Abstract][Full Text] [Related]
12. Assessing the relationship between monoallelic PRKN mutations and Parkinson's risk.
Lubbe SJ; Bustos BI; Hu J; Krainc D; Joseph T; Hehir J; Tan M; Zhang W; Escott-Price V; Williams NM; Blauwendraat C; Singleton AB; Morris HR;
Hum Mol Genet; 2021 Mar; 30(1):78-86. PubMed ID: 33448283
[TBL] [Abstract][Full Text] [Related]
13. Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene.
Azevedo C; Chumarina M; Serafimova E; Goldwurm S; Collin A; Roybon L; Savchenko E; Pomeshchik Y
Stem Cell Res; 2020 Mar; 43():101694. PubMed ID: 31954327
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson's disease.
Trinh J; Hicks AA; König IR; Delcambre S; Lüth T; Schaake S; Wasner K; Ghelfi J; Borsche M; Vilariño-Güell C; Hentati F; Germer EL; Bauer P; Takanashi M; Kostić V; Lang AE; Brüggemann N; Pramstaller PP; Pichler I; Rajput A; Hattori N; Farrer MJ; Lohmann K; Weissensteiner H; May P; Klein C; Grünewald A
Brain; 2023 Jul; 146(7):2753-2765. PubMed ID: 36478228
[TBL] [Abstract][Full Text] [Related]
15. Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease.
Daida K; Funayama M; Billingsley KJ; Malik L; Miano-Burkhardt A; Leonard HL; Makarious MB; Iwaki H; Ding J; Gibbs JR; Ishiguro M; Yoshino H; Ogaki K; Oyama G; Nishioka K; Nonaka R; Akamatsu W; Blauwendraat C; Hattori N
Mov Disord; 2023 Dec; 38(12):2249-2257. PubMed ID: 37926948
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations.
Deng H; Le WD; Hunter CB; Ondo WG; Guo Y; Xie WJ; Jankovic J
Arch Neurol; 2006 Feb; 63(2):273-7. PubMed ID: 16476817
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Exon Dosage Using Multiplex Ligation-Dependent Probe Amplification in Chinese Patients with Early-Onset Parkinson's Disease.
Lin Y; Zeng YF; Cai NQ; Lin XZ; Wang N; He J
Eur Neurol; 2019; 81(5-6):246-253. PubMed ID: 31618739
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
[TBL] [Abstract][Full Text] [Related]
19. Frequency of Heterozygous Parkin (
Castelo Rueda MP; Raftopoulou A; Gögele M; Borsche M; Emmert D; Fuchsberger C; Hantikainen EM; Vukovic V; Klein C; Pramstaller PP; Pichler I; Hicks AA
Front Neurol; 2021; 12():706145. PubMed ID: 34434164
[TBL] [Abstract][Full Text] [Related]
20. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
